nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—Monoamine Transport—SLC6A4—migraine	0.00875	0.0702	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—RAMP1—migraine	0.00723	0.0581	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—CALCRL—migraine	0.00723	0.0581	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—EDNRA—migraine	0.00369	0.0296	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—HTR7—migraine	0.00332	0.0267	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—NPS—migraine	0.00302	0.0242	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00292	0.0235	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—CALCA—migraine	0.00277	0.0223	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00272	0.0218	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CALCRL—migraine	0.00263	0.0211	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—RAMP1—migraine	0.00263	0.0211	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—HTR7—migraine	0.00259	0.0208	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00251	0.0201	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00233	0.0187	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—HTR2A—migraine	0.00233	0.0187	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—TNF—migraine	0.00231	0.0185	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NPS—migraine	0.00205	0.0165	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—SLC6A4—migraine	0.00201	0.0162	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR1D—migraine	0.00191	0.0153	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2B—migraine	0.00177	0.0142	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00177	0.0142	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—HTR7—migraine	0.00176	0.0141	CbGpPWpGaD
Regadenoson—Tinnitus—Valproic Acid—migraine	0.00173	0.00198	CcSEcCtD
Regadenoson—Pain—Propranolol—migraine	0.00173	0.00198	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00171	0.0137	CbGpPWpGaD
Regadenoson—Diarrhoea—Amitriptyline—migraine	0.0017	0.00194	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Verapamil—migraine	0.00169	0.00194	CcSEcCtD
Regadenoson—Acute coronary syndrome—Gabapentin—migraine	0.00169	0.00193	CcSEcCtD
Regadenoson—Renal failure—Gabapentin—migraine	0.00169	0.00193	CcSEcCtD
Regadenoson—Angiopathy—Valproic Acid—migraine	0.00168	0.00192	CcSEcCtD
Regadenoson—Insomnia—Verapamil—migraine	0.00168	0.00192	CcSEcCtD
Regadenoson—Bradycardia—Timolol—migraine	0.00168	0.00192	CcSEcCtD
Regadenoson—Myocardial infarction—Gabapentin—migraine	0.00168	0.00192	CcSEcCtD
Regadenoson—Immune system disorder—Valproic Acid—migraine	0.00168	0.00192	CcSEcCtD
Regadenoson—Mediastinal disorder—Valproic Acid—migraine	0.00167	0.00191	CcSEcCtD
Regadenoson—Paraesthesia—Verapamil—migraine	0.00167	0.00191	CcSEcCtD
Regadenoson—Dyspnoea—Verapamil—migraine	0.00166	0.00189	CcSEcCtD
Regadenoson—Somnolence—Verapamil—migraine	0.00165	0.00189	CcSEcCtD
Regadenoson—Gastrointestinal pain—Propranolol—migraine	0.00165	0.00189	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00165	0.0132	CbGpPWpGaD
Regadenoson—Dizziness—Amitriptyline—migraine	0.00164	0.00188	CcSEcCtD
Regadenoson—Abdominal distension—Topiramate—migraine	0.00163	0.00186	CcSEcCtD
Regadenoson—Mental disorder—Valproic Acid—migraine	0.00163	0.00186	CcSEcCtD
Regadenoson—Connective tissue disorder—Timolol—migraine	0.00162	0.00186	CcSEcCtD
Regadenoson—Asthma—Topiramate—migraine	0.00162	0.00185	CcSEcCtD
Regadenoson—Urticaria—Propranolol—migraine	0.00161	0.00184	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.0016	0.0129	CbGpPWpGaD
Regadenoson—Abdominal pain—Propranolol—migraine	0.0016	0.00183	CcSEcCtD
Regadenoson—Pain—Verapamil—migraine	0.00159	0.00182	CcSEcCtD
Regadenoson—Dysgeusia—Valproic Acid—migraine	0.00158	0.00181	CcSEcCtD
Regadenoson—Vomiting—Amitriptyline—migraine	0.00158	0.0018	CcSEcCtD
Regadenoson—Angina pectoris—Topiramate—migraine	0.00158	0.0018	CcSEcCtD
Regadenoson—Bradycardia—Gabapentin—migraine	0.00157	0.00179	CcSEcCtD
Regadenoson—Rash—Amitriptyline—migraine	0.00157	0.00179	CcSEcCtD
Regadenoson—Dermatitis—Amitriptyline—migraine	0.00156	0.00179	CcSEcCtD
Regadenoson—Headache—Amitriptyline—migraine	0.00156	0.00178	CcSEcCtD
Regadenoson—Abdominal discomfort—Topiramate—migraine	0.00155	0.00177	CcSEcCtD
Regadenoson—Eye disorder—Timolol—migraine	0.00154	0.00176	CcSEcCtD
Regadenoson—Tinnitus—Timolol—migraine	0.00154	0.00176	CcSEcCtD
Regadenoson—Cardiac disorder—Timolol—migraine	0.00153	0.00175	CcSEcCtD
Regadenoson—Feeling abnormal—Verapamil—migraine	0.00153	0.00175	CcSEcCtD
Regadenoson—Hypoaesthesia—Gabapentin—migraine	0.00153	0.00175	CcSEcCtD
Regadenoson—Vision blurred—Valproic Acid—migraine	0.00152	0.00174	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00152	0.0122	CbGpPWpGaD
Regadenoson—Tremor—Valproic Acid—migraine	0.00151	0.00173	CcSEcCtD
Regadenoson—Connective tissue disorder—Gabapentin—migraine	0.00151	0.00173	CcSEcCtD
Regadenoson—Ill-defined disorder—Valproic Acid—migraine	0.0015	0.00171	CcSEcCtD
Regadenoson—Angiopathy—Timolol—migraine	0.0015	0.00171	CcSEcCtD
Regadenoson—Immune system disorder—Timolol—migraine	0.00149	0.00171	CcSEcCtD
Regadenoson—Hypersensitivity—Propranolol—migraine	0.00149	0.0017	CcSEcCtD
Regadenoson—Mediastinal disorder—Timolol—migraine	0.00149	0.0017	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CALCRL—migraine	0.00148	0.0119	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—RAMP1—migraine	0.00148	0.0119	CbGpPWpGaD
Regadenoson—Urticaria—Verapamil—migraine	0.00148	0.00169	CcSEcCtD
Regadenoson—Angioedema—Valproic Acid—migraine	0.00148	0.00169	CcSEcCtD
Regadenoson—Nausea—Amitriptyline—migraine	0.00148	0.00169	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00146	0.0117	CbGpPWpGaD
Regadenoson—Malaise—Valproic Acid—migraine	0.00146	0.00166	CcSEcCtD
Regadenoson—Asthenia—Propranolol—migraine	0.00145	0.00166	CcSEcCtD
Regadenoson—Mental disorder—Timolol—migraine	0.00145	0.00165	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00144	0.0116	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00144	0.0116	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00144	0.0116	CbGpPWpGaD
Regadenoson—Erythema—Timolol—migraine	0.00144	0.00164	CcSEcCtD
Regadenoson—Eye disorder—Gabapentin—migraine	0.00144	0.00164	CcSEcCtD
Regadenoson—Tinnitus—Gabapentin—migraine	0.00144	0.00164	CcSEcCtD
Regadenoson—Cardiac disorder—Gabapentin—migraine	0.00143	0.00163	CcSEcCtD
Regadenoson—Palpitations—Valproic Acid—migraine	0.00143	0.00163	CcSEcCtD
Regadenoson—Renal failure—Topiramate—migraine	0.00142	0.00162	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00141	0.0113	CbGpPWpGaD
Regadenoson—Cough—Valproic Acid—migraine	0.00141	0.00161	CcSEcCtD
Regadenoson—Dysgeusia—Timolol—migraine	0.00141	0.00161	CcSEcCtD
Regadenoson—Hypertension—Valproic Acid—migraine	0.0014	0.00159	CcSEcCtD
Regadenoson—Immune system disorder—Gabapentin—migraine	0.00139	0.00159	CcSEcCtD
Regadenoson—Mediastinal disorder—Gabapentin—migraine	0.00139	0.00158	CcSEcCtD
Regadenoson—Diarrhoea—Propranolol—migraine	0.00138	0.00158	CcSEcCtD
Regadenoson—Arthralgia—Valproic Acid—migraine	0.00138	0.00157	CcSEcCtD
Regadenoson—Chest pain—Valproic Acid—migraine	0.00138	0.00157	CcSEcCtD
Regadenoson—Myalgia—Valproic Acid—migraine	0.00138	0.00157	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00137	0.011	CbGpPWpGaD
Regadenoson—Anxiety—Valproic Acid—migraine	0.00137	0.00157	CcSEcCtD
Regadenoson—Hypersensitivity—Verapamil—migraine	0.00137	0.00157	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00137	0.00156	CcSEcCtD
Regadenoson—Discomfort—Valproic Acid—migraine	0.00136	0.00155	CcSEcCtD
Regadenoson—Vision blurred—Timolol—migraine	0.00136	0.00155	CcSEcCtD
Regadenoson—Mental disorder—Gabapentin—migraine	0.00135	0.00154	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CALCRL—migraine	0.00135	0.0108	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—RAMP1—migraine	0.00135	0.0108	CbGpPWpGaD
Regadenoson—Erythema—Gabapentin—migraine	0.00134	0.00153	CcSEcCtD
Regadenoson—Dizziness—Propranolol—migraine	0.00134	0.00153	CcSEcCtD
Regadenoson—Asthenia—Verapamil—migraine	0.00133	0.00152	CcSEcCtD
Regadenoson—Anaphylactic shock—Valproic Acid—migraine	0.00132	0.00151	CcSEcCtD
Regadenoson—Bradycardia—Topiramate—migraine	0.00132	0.00151	CcSEcCtD
Regadenoson—Angioedema—Timolol—migraine	0.00131	0.0015	CcSEcCtD
Regadenoson—Dysgeusia—Gabapentin—migraine	0.00131	0.0015	CcSEcCtD
Regadenoson—Nervous system disorder—Valproic Acid—migraine	0.00129	0.00148	CcSEcCtD
Regadenoson—Syncope—Timolol—migraine	0.00129	0.00147	CcSEcCtD
Regadenoson—Hypoaesthesia—Topiramate—migraine	0.00129	0.00147	CcSEcCtD
Regadenoson—Tachycardia—Valproic Acid—migraine	0.00129	0.00147	CcSEcCtD
Regadenoson—Vomiting—Propranolol—migraine	0.00129	0.00147	CcSEcCtD
Regadenoson—Skin disorder—Valproic Acid—migraine	0.00128	0.00146	CcSEcCtD
Regadenoson—Hyperhidrosis—Valproic Acid—migraine	0.00128	0.00146	CcSEcCtD
Regadenoson—Rash—Propranolol—migraine	0.00128	0.00146	CcSEcCtD
Regadenoson—Dermatitis—Propranolol—migraine	0.00127	0.00146	CcSEcCtD
Regadenoson—Diarrhoea—Verapamil—migraine	0.00127	0.00145	CcSEcCtD
Regadenoson—Connective tissue disorder—Topiramate—migraine	0.00127	0.00145	CcSEcCtD
Regadenoson—Palpitations—Timolol—migraine	0.00127	0.00145	CcSEcCtD
Regadenoson—Loss of consciousness—Timolol—migraine	0.00126	0.00144	CcSEcCtD
Regadenoson—Vision blurred—Gabapentin—migraine	0.00126	0.00144	CcSEcCtD
Regadenoson—Cough—Timolol—migraine	0.00126	0.00143	CcSEcCtD
Regadenoson—Tremor—Gabapentin—migraine	0.00126	0.00143	CcSEcCtD
Regadenoson—Ill-defined disorder—Gabapentin—migraine	0.00124	0.00142	CcSEcCtD
Regadenoson—Hypertension—Timolol—migraine	0.00124	0.00142	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00124	0.00993	CbGpPWpGaD
Regadenoson—Hypotension—Valproic Acid—migraine	0.00123	0.00141	CcSEcCtD
Regadenoson—Dizziness—Verapamil—migraine	0.00123	0.00141	CcSEcCtD
Regadenoson—Myalgia—Timolol—migraine	0.00122	0.0014	CcSEcCtD
Regadenoson—Chest pain—Timolol—migraine	0.00122	0.0014	CcSEcCtD
Regadenoson—Arthralgia—Timolol—migraine	0.00122	0.0014	CcSEcCtD
Regadenoson—Angioedema—Gabapentin—migraine	0.00122	0.0014	CcSEcCtD
Regadenoson—Anxiety—Timolol—migraine	0.00122	0.00139	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00122	0.00139	CcSEcCtD
Regadenoson—Discomfort—Timolol—migraine	0.00121	0.00138	CcSEcCtD
Regadenoson—Eye disorder—Topiramate—migraine	0.00121	0.00138	CcSEcCtD
Regadenoson—Malaise—Gabapentin—migraine	0.00121	0.00138	CcSEcCtD
Regadenoson—Tinnitus—Topiramate—migraine	0.00121	0.00138	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Valproic Acid—migraine	0.0012	0.00137	CcSEcCtD
Regadenoson—Flushing—Topiramate—migraine	0.0012	0.00137	CcSEcCtD
Regadenoson—Cardiac disorder—Topiramate—migraine	0.0012	0.00137	CcSEcCtD
Regadenoson—Syncope—Gabapentin—migraine	0.0012	0.00137	CcSEcCtD
Regadenoson—Nausea—Propranolol—migraine	0.0012	0.00137	CcSEcCtD
Regadenoson—Insomnia—Valproic Acid—migraine	0.00119	0.00136	CcSEcCtD
Regadenoson—Paraesthesia—Valproic Acid—migraine	0.00118	0.00135	CcSEcCtD
Regadenoson—Palpitations—Gabapentin—migraine	0.00118	0.00135	CcSEcCtD
Regadenoson—Vomiting—Verapamil—migraine	0.00118	0.00135	CcSEcCtD
Regadenoson—Loss of consciousness—Gabapentin—migraine	0.00118	0.00135	CcSEcCtD
Regadenoson—Dyspnoea—Valproic Acid—migraine	0.00118	0.00134	CcSEcCtD
Regadenoson—Angiopathy—Topiramate—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Anaphylactic shock—Timolol—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Rash—Verapamil—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Somnolence—Valproic Acid—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Dermatitis—Verapamil—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Immune system disorder—Topiramate—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Cough—Gabapentin—migraine	0.00117	0.00134	CcSEcCtD
Regadenoson—Mediastinal disorder—Topiramate—migraine	0.00117	0.00133	CcSEcCtD
Regadenoson—Headache—Verapamil—migraine	0.00117	0.00133	CcSEcCtD
Regadenoson—Convulsion—Gabapentin—migraine	0.00116	0.00133	CcSEcCtD
Regadenoson—Hypertension—Gabapentin—migraine	0.00116	0.00132	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR1B—migraine	0.00116	0.00928	CbGpPWpGaD
Regadenoson—Shock—Timolol—migraine	0.00116	0.00132	CcSEcCtD
Regadenoson—Nervous system disorder—Timolol—migraine	0.00115	0.00132	CcSEcCtD
Regadenoson—Chest pain—Gabapentin—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Arthralgia—Gabapentin—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Myalgia—Gabapentin—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Skin disorder—Timolol—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Valproic Acid—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Anxiety—Gabapentin—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Hyperhidrosis—Timolol—migraine	0.00114	0.0013	CcSEcCtD
Regadenoson—Mental disorder—Topiramate—migraine	0.00113	0.0013	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00113	0.00129	CcSEcCtD
Regadenoson—Pain—Valproic Acid—migraine	0.00113	0.00129	CcSEcCtD
Regadenoson—Erythema—Topiramate—migraine	0.00113	0.00129	CcSEcCtD
Regadenoson—Discomfort—Gabapentin—migraine	0.00113	0.00129	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR1A—migraine	0.00111	0.00894	CbGpPWpGaD
Regadenoson—Nausea—Verapamil—migraine	0.00111	0.00126	CcSEcCtD
Regadenoson—Dysgeusia—Topiramate—migraine	0.0011	0.00126	CcSEcCtD
Regadenoson—Hypotension—Timolol—migraine	0.0011	0.00125	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—NPS—migraine	0.0011	0.0088	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—TAC1—migraine	0.0011	0.0088	CbGpPWpGaD
Regadenoson—Anaphylactic shock—Gabapentin—migraine	0.00109	0.00125	CcSEcCtD
Regadenoson—Feeling abnormal—Valproic Acid—migraine	0.00109	0.00124	CcSEcCtD
Regadenoson—Gastrointestinal pain—Valproic Acid—migraine	0.00108	0.00123	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR1D—migraine	0.00108	0.00866	CbGpPWpGaD
Regadenoson—Shock—Gabapentin—migraine	0.00108	0.00123	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2C—migraine	0.00107	0.00863	CbGpPWpGaD
Regadenoson—Nervous system disorder—Gabapentin—migraine	0.00107	0.00122	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Timolol—migraine	0.00107	0.00122	CcSEcCtD
Regadenoson—Tachycardia—Gabapentin—migraine	0.00107	0.00122	CcSEcCtD
Regadenoson—Vision blurred—Topiramate—migraine	0.00106	0.00121	CcSEcCtD
Regadenoson—Skin disorder—Gabapentin—migraine	0.00106	0.00121	CcSEcCtD
Regadenoson—Insomnia—Timolol—migraine	0.00106	0.00121	CcSEcCtD
Regadenoson—Hyperhidrosis—Gabapentin—migraine	0.00106	0.00121	CcSEcCtD
Regadenoson—Tremor—Topiramate—migraine	0.00106	0.00121	CcSEcCtD
Regadenoson—Paraesthesia—Timolol—migraine	0.00105	0.0012	CcSEcCtD
Regadenoson—Urticaria—Valproic Acid—migraine	0.00105	0.0012	CcSEcCtD
Regadenoson—Dyspnoea—Timolol—migraine	0.00105	0.0012	CcSEcCtD
Regadenoson—Ill-defined disorder—Topiramate—migraine	0.00105	0.00119	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—EDNRA—migraine	0.00105	0.00839	CbGpPWpGaD
Regadenoson—Somnolence—Timolol—migraine	0.00104	0.00119	CcSEcCtD
Regadenoson—Abdominal pain—Valproic Acid—migraine	0.00104	0.00119	CcSEcCtD
Regadenoson—Hypotension—Gabapentin—migraine	0.00102	0.00117	CcSEcCtD
Regadenoson—Malaise—Topiramate—migraine	0.00102	0.00116	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Timolol—migraine	0.00101	0.00116	CcSEcCtD
Regadenoson—Syncope—Topiramate—migraine	0.00101	0.00115	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00101	0.00811	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CALCA—migraine	0.00101	0.00808	CbGpPWpGaD
Regadenoson—Pain—Timolol—migraine	0.001	0.00115	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2B—migraine	0.001	0.00805	CbGpPWpGaD
Regadenoson—Musculoskeletal discomfort—Gabapentin—migraine	0.000996	0.00114	CcSEcCtD
Regadenoson—Palpitations—Topiramate—migraine	0.000996	0.00114	CcSEcCtD
Regadenoson—Loss of consciousness—Topiramate—migraine	0.000991	0.00113	CcSEcCtD
Regadenoson—Insomnia—Gabapentin—migraine	0.000989	0.00113	CcSEcCtD
Regadenoson—Cough—Topiramate—migraine	0.000984	0.00112	CcSEcCtD
Regadenoson—Paraesthesia—Gabapentin—migraine	0.000982	0.00112	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—HTR1D—migraine	0.000979	0.00786	CbGpPWpGaD
Regadenoson—Convulsion—Topiramate—migraine	0.000977	0.00112	CcSEcCtD
Regadenoson—Dyspnoea—Gabapentin—migraine	0.000975	0.00111	CcSEcCtD
Regadenoson—Hypertension—Topiramate—migraine	0.000973	0.00111	CcSEcCtD
Regadenoson—Somnolence—Gabapentin—migraine	0.000972	0.00111	CcSEcCtD
Regadenoson—Hypersensitivity—Valproic Acid—migraine	0.000972	0.00111	CcSEcCtD
Regadenoson—Feeling abnormal—Timolol—migraine	0.000968	0.00111	CcSEcCtD
Regadenoson—Gastrointestinal pain—Timolol—migraine	0.00096	0.0011	CcSEcCtD
Regadenoson—Chest pain—Topiramate—migraine	0.00096	0.0011	CcSEcCtD
Regadenoson—Arthralgia—Topiramate—migraine	0.00096	0.0011	CcSEcCtD
Regadenoson—Myalgia—Topiramate—migraine	0.00096	0.0011	CcSEcCtD
Regadenoson—Anxiety—Topiramate—migraine	0.000956	0.00109	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000953	0.00109	CcSEcCtD
Regadenoson—Discomfort—Topiramate—migraine	0.000948	0.00108	CcSEcCtD
Regadenoson—Asthenia—Valproic Acid—migraine	0.000946	0.00108	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Gabapentin—migraine	0.000944	0.00108	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR7—migraine	0.000941	0.00756	CbGpPWpGaD
Regadenoson—Pain—Gabapentin—migraine	0.000935	0.00107	CcSEcCtD
Regadenoson—Urticaria—Timolol—migraine	0.000933	0.00107	CcSEcCtD
Regadenoson—Abdominal pain—Timolol—migraine	0.000928	0.00106	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2B—migraine	0.00091	0.00731	CbGpPWpGaD
Regadenoson—Shock—Topiramate—migraine	0.000905	0.00103	CcSEcCtD
Regadenoson—Diarrhoea—Valproic Acid—migraine	0.000903	0.00103	CcSEcCtD
Regadenoson—Nervous system disorder—Topiramate—migraine	0.000902	0.00103	CcSEcCtD
Regadenoson—Feeling abnormal—Gabapentin—migraine	0.000901	0.00103	CcSEcCtD
Regadenoson—Tachycardia—Topiramate—migraine	0.000898	0.00103	CcSEcCtD
Regadenoson—Gastrointestinal pain—Gabapentin—migraine	0.000894	0.00102	CcSEcCtD
Regadenoson—Skin disorder—Topiramate—migraine	0.000894	0.00102	CcSEcCtD
Regadenoson—Hyperhidrosis—Topiramate—migraine	0.000889	0.00102	CcSEcCtD
Regadenoson—Dizziness—Valproic Acid—migraine	0.000872	0.000996	CcSEcCtD
Regadenoson—Urticaria—Gabapentin—migraine	0.000869	0.000992	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000866	0.00695	CbGpPWpGaD
Regadenoson—Hypersensitivity—Timolol—migraine	0.000865	0.000988	CcSEcCtD
Regadenoson—Abdominal pain—Gabapentin—migraine	0.000864	0.000987	CcSEcCtD
Regadenoson—Hypotension—Topiramate—migraine	0.00086	0.000982	CcSEcCtD
Regadenoson—Asthenia—Timolol—migraine	0.000842	0.000962	CcSEcCtD
Regadenoson—Vomiting—Valproic Acid—migraine	0.000839	0.000958	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Topiramate—migraine	0.000838	0.000957	CcSEcCtD
Regadenoson—Insomnia—Topiramate—migraine	0.000832	0.00095	CcSEcCtD
Regadenoson—Rash—Valproic Acid—migraine	0.000832	0.00095	CcSEcCtD
Regadenoson—Dermatitis—Valproic Acid—migraine	0.000831	0.000949	CcSEcCtD
Regadenoson—Headache—Valproic Acid—migraine	0.000826	0.000944	CcSEcCtD
Regadenoson—Paraesthesia—Topiramate—migraine	0.000826	0.000944	CcSEcCtD
Regadenoson—Dyspnoea—Topiramate—migraine	0.00082	0.000937	CcSEcCtD
Regadenoson—Somnolence—Topiramate—migraine	0.000818	0.000934	CcSEcCtD
Regadenoson—Hypersensitivity—Gabapentin—migraine	0.000806	0.00092	CcSEcCtD
Regadenoson—Diarrhoea—Timolol—migraine	0.000803	0.000918	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—RAMP1—migraine	0.000796	0.00639	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CALCRL—migraine	0.000796	0.00639	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Topiramate—migraine	0.000794	0.000907	CcSEcCtD
Regadenoson—Pain—Topiramate—migraine	0.000787	0.000899	CcSEcCtD
Regadenoson—Asthenia—Gabapentin—migraine	0.000785	0.000896	CcSEcCtD
Regadenoson—Nausea—Valproic Acid—migraine	0.000784	0.000895	CcSEcCtD
Regadenoson—Dizziness—Timolol—migraine	0.000777	0.000887	CcSEcCtD
Regadenoson—Feeling abnormal—Topiramate—migraine	0.000758	0.000866	CcSEcCtD
Regadenoson—Gastrointestinal pain—Topiramate—migraine	0.000752	0.000859	CcSEcCtD
Regadenoson—Diarrhoea—Gabapentin—migraine	0.000748	0.000855	CcSEcCtD
Regadenoson—Vomiting—Timolol—migraine	0.000747	0.000853	CcSEcCtD
Regadenoson—Rash—Timolol—migraine	0.00074	0.000846	CcSEcCtD
Regadenoson—Dermatitis—Timolol—migraine	0.00074	0.000845	CcSEcCtD
Regadenoson—Headache—Timolol—migraine	0.000736	0.00084	CcSEcCtD
Regadenoson—Urticaria—Topiramate—migraine	0.000731	0.000835	CcSEcCtD
Regadenoson—Abdominal pain—Topiramate—migraine	0.000727	0.000831	CcSEcCtD
Regadenoson—Dizziness—Gabapentin—migraine	0.000723	0.000826	CcSEcCtD
Regadenoson—Nausea—Timolol—migraine	0.000697	0.000797	CcSEcCtD
Regadenoson—Vomiting—Gabapentin—migraine	0.000695	0.000794	CcSEcCtD
Regadenoson—Rash—Gabapentin—migraine	0.000689	0.000788	CcSEcCtD
Regadenoson—Dermatitis—Gabapentin—migraine	0.000689	0.000787	CcSEcCtD
Regadenoson—Headache—Gabapentin—migraine	0.000685	0.000782	CcSEcCtD
Regadenoson—Hypersensitivity—Topiramate—migraine	0.000678	0.000774	CcSEcCtD
Regadenoson—Asthenia—Topiramate—migraine	0.00066	0.000754	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2A—migraine	0.000659	0.00529	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR1B—migraine	0.000653	0.00525	CbGpPWpGaD
Regadenoson—Nausea—Gabapentin—migraine	0.00065	0.000742	CcSEcCtD
Regadenoson—Diarrhoea—Topiramate—migraine	0.000629	0.000719	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR1A—migraine	0.000629	0.00505	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TAC1—migraine	0.000619	0.00497	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPS—migraine	0.000619	0.00497	CbGpPWpGaD
Regadenoson—Dizziness—Topiramate—migraine	0.000608	0.000695	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2C—migraine	0.000607	0.00488	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR1B—migraine	0.000593	0.00476	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDNRA—migraine	0.000591	0.00474	CbGpPWpGaD
Regadenoson—Vomiting—Topiramate—migraine	0.000585	0.000668	CcSEcCtD
Regadenoson—Rash—Topiramate—migraine	0.00058	0.000663	CcSEcCtD
Regadenoson—Dermatitis—Topiramate—migraine	0.00058	0.000662	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HTR1D—migraine	0.000578	0.00464	CbGpPWpGaD
Regadenoson—Headache—Topiramate—migraine	0.000576	0.000658	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—HTR1A—migraine	0.000571	0.00459	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CALCA—migraine	0.000569	0.00457	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TAC1—migraine	0.000562	0.00452	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPS—migraine	0.000562	0.00452	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2C—migraine	0.000551	0.00443	CbGpPWpGaD
Regadenoson—Nausea—Topiramate—migraine	0.000546	0.000624	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HTR2B—migraine	0.000538	0.00432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDNRA—migraine	0.000536	0.00431	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR7—migraine	0.000532	0.00427	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CALCA—migraine	0.000516	0.00415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR7—migraine	0.000483	0.00388	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LRP1—migraine	0.000473	0.0038	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2A—migraine	0.000373	0.00299	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOTCH4—migraine	0.000363	0.00292	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR1B—migraine	0.00035	0.00281	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2A—migraine	0.000338	0.00272	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR1A—migraine	0.000337	0.00271	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TAC1—migraine	0.000332	0.00267	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NPS—migraine	0.000332	0.00267	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PGR—migraine	0.000332	0.00267	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2C—migraine	0.000326	0.00262	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDNRA—migraine	0.000317	0.00254	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOTCH3—migraine	0.000309	0.00248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CALCA—migraine	0.000305	0.00245	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR7—migraine	0.000285	0.00229	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFBR2—migraine	0.000246	0.00197	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2A—migraine	0.0002	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ESR1—migraine	0.000177	0.00142	CbGpPWpGaD
